DE1617488A1 - Verfahren zur Herstellung von Arzneimittel,Anregungsmitteln und Genussmitteln - Google Patents
Verfahren zur Herstellung von Arzneimittel,Anregungsmitteln und GenussmittelnInfo
- Publication number
- DE1617488A1 DE1617488A1 DE19661617488 DE1617488A DE1617488A1 DE 1617488 A1 DE1617488 A1 DE 1617488A1 DE 19661617488 DE19661617488 DE 19661617488 DE 1617488 A DE1617488 A DE 1617488A DE 1617488 A1 DE1617488 A1 DE 1617488A1
- Authority
- DE
- Germany
- Prior art keywords
- emetic
- production
- active substance
- drug
- stimulants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims description 13
- 238000000034 method Methods 0.000 title claims description 7
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- 235000013305 food Nutrition 0.000 title description 2
- 239000000021 stimulant Substances 0.000 title description 2
- 239000002895 emetic Substances 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 10
- 206010028813 Nausea Diseases 0.000 claims description 3
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 claims description 3
- 229960004046 apomorphine Drugs 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000008693 nausea Effects 0.000 claims description 2
- 244000284152 Carapichea ipecacuanha Species 0.000 claims 1
- 239000009471 Ipecac Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 230000005284 excitation Effects 0.000 claims 1
- 229940029408 ipecac Drugs 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000013543 active substance Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 206010047700 Vomiting Diseases 0.000 description 3
- 229940125717 barbiturate Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000008043 acidic salts Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44370065A | 1965-03-29 | 1965-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1617488A1 true DE1617488A1 (de) | 1971-03-18 |
Family
ID=23761856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661617488 Pending DE1617488A1 (de) | 1965-03-29 | 1966-03-26 | Verfahren zur Herstellung von Arzneimittel,Anregungsmitteln und Genussmitteln |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE1617488A1 (enrdf_load_stackoverflow) |
| FR (1) | FR5231M (enrdf_load_stackoverflow) |
| GB (1) | GB1138154A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2162061B (en) * | 1984-05-03 | 1988-11-16 | Bibhuti B Bardhan | Controlled time release therapeutic composition having means for counteracting overdosage |
-
1966
- 1966-03-26 DE DE19661617488 patent/DE1617488A1/de active Pending
- 1966-03-28 FR FR55167A patent/FR5231M/fr not_active Expired
- 1966-03-28 GB GB1361566A patent/GB1138154A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1138154A (en) | 1968-12-27 |
| FR5231M (enrdf_load_stackoverflow) | 1967-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69419019T2 (de) | Gelatinekaiseln die eine hochdosierte acetaminophenlösung enthalten | |
| DE69127456T2 (de) | Gelatinkapseln substituiert durch stärke mit hohem amyloseanteil | |
| DE19541128C2 (de) | Stabilisierte schilddrüsenhormonhaltige Arzneimittel | |
| DE60020501T3 (de) | Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe | |
| DE69429632T2 (de) | Dosisform mit gesteuerter freigabe für kalium | |
| DD201643A5 (de) | Verfahren zur herstellung einer acetylsalicylsaeurehaltigen kapsel | |
| Cutler et al. | A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial | |
| CH647150A5 (de) | Zubereitung, enthaltend ein tranquillans und ein propiophenon. | |
| DE3023588C2 (de) | Verwendung von Clonidin oder dessen Hydrochlorid zusammen mit Phentermin zum Abgewöhnen des Rauchens | |
| DE69534283T2 (de) | Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe | |
| DE3116860C2 (enrdf_load_stackoverflow) | ||
| DE2520978C3 (de) | Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten | |
| DE1617488A1 (de) | Verfahren zur Herstellung von Arzneimittel,Anregungsmitteln und Genussmitteln | |
| Handschumacher et al. | Pharmacological and clinical studies with triacetyl 6-azauridine | |
| DE2126810A1 (de) | Verfahren zur Herstellung von Tab letten | |
| Bennett | Propoxyphene napsylate for heroin addiction | |
| DE2821311A1 (de) | Arzneimittel enthaltend fusarsaeure | |
| DE69103294T2 (de) | Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten. | |
| DE2352618A1 (de) | Arzneimittel zur behandlung des parkinsonismus | |
| WO1995016450A1 (de) | Verwendung von pentoxifyllin zur behandlung von multipler sklerose | |
| Lake et al. | Response: Elevated Cerebrospinal Fluid Norepinephrine in Schizophrenics: Confounding Effects of Treatment Drugs | |
| Torosian et al. | Hazards of bromides in proprietary medication | |
| AT234277B (de) | Verfahren zur Herstellung oral verabreichbarer Eisenpräparate | |
| DE7109579U (de) | Vorrichtung zur Aufmachung pharma zeutischer Produkte | |
| Lipsky | Elevated cerebrospinal fluid norepinephrine in schizophrenics: confounding effects of treatment drugs |